Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers

  • Read more about Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers
Japan
2017-567058
Filed on 2017-12-25

COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME

  • Read more about COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME
Japan
2023-575827
Filed on 2023-12-08

ANTI-KRAS-G12D T CELL RECEPTORS

  • Read more about ANTI-KRAS-G12D T CELL RECEPTORS
US Application 18/423,020
Filed on 2024-01-25

TEM8 ANTIBODIES AND THEIR USE

  • Read more about TEM8 ANTIBODIES AND THEIR USE
Hong Kong
42020013010.2
Filed on 2014-10-13

TEM8 Antibodies and Their Use

  • Read more about TEM8 Antibodies and Their Use
Australia
2022200117
Filed on 2019-10-24

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

  • Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Costa Rica
2024-0019
Filed on 2024-01-11

COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER

  • Read more about COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER
US Application 18/568,661
Filed on 2023-12-08

PKM1/HLT2 NANOPARTICLE/HYDROGEL COMPOSITE FOR MIRNA DELIVERY

  • Read more about PKM1/HLT2 NANOPARTICLE/HYDROGEL COMPOSITE FOR MIRNA DELIVERY
Patent Cooperation Treaty
PCT/US2024/011463
Filed on 2024-01-12

MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

  • Read more about MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
Japan
2023-205633
Filed on 2023-12-05

MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

  • Read more about MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
Japan
2022-177351
Filed on 2022-11-04

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 241
  • Page 242
  • Page 243
  • Page 244
  • Page 245
  • Page 246
  • Page 247
  • Page 248
  • Page 249
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health